TrovaGene, Inc. is a developer of molecular diagnostics products based on the detection of transrenal genetic markers. These cell-free nucleic fragments pass through the kidney and are detectable in the urine.
Targeting transrenal markers will allow us and our partners to develop genetic testing using simple to obtain urine samples rather than the more invasive methods or traditional blood testing.
Transrenal molecular tests will make it easier to address important health problems worldwide and will lead to significant advancements in personalized medicine for improved patient care.
